Fibroblasts and Endothelial Cells in Three-Dimensional Models: A New Tool for Addressing the Pathogenesis of Systemic Sclerosis as a Prototype of Fibrotic Vasculopathies

Int J Mol Sci. 2024 Feb 28;25(5):2780. doi: 10.3390/ijms25052780.

Abstract

Two-dimensional in vitro cultures have represented a milestone in biomedical and pharmacological research. However, they cannot replicate the architecture and interactions of in vivo tissues. Moreover, ethical issues regarding the use of animals have triggered strategies alternative to animal models. The development of three-dimensional (3D) models offers a relevant tool to investigate disease pathogenesis and treatment, modeling in vitro the in vivo environment. We aimed to develop a dynamic 3D in vitro model for culturing human endothelial cells (ECs) and skin fibroblasts, simulating the structure of the tissues mainly affected in systemic sclerosis (SSc), a prototypical autoimmune fibrotic vasculopathy. Dermal fibroblasts and umbilical vein ECs grown in scaffold or hydrogel, respectively, were housed in bioreactors under flow. Fibroblasts formed a tissue-like texture with the deposition of a new extracellular matrix (ECM) and ECs assembled tube-shaped structures with cell polarization. The fine-tuned dynamic modular system allowing 3D fibroblast/EC culture connection represents a valuable model of the in vivo interplay between the main players in fibrotic vasculopathy as SSc. This model can lead to a more accurate study of the disease's pathogenesis, avoiding the use of animals, and to the development of novel therapies, possibly resulting in improved patient management.

Keywords: dynamic culture; endothelial cells; fibroblasts; hydrogel; scaffold; systemic sclerosis; three-dimensional models.

MeSH terms

  • Animals
  • Cells, Cultured
  • Endothelial Cells / pathology
  • Fibroblasts / pathology
  • Fibrosis
  • Humans
  • Scleroderma, Systemic* / pathology
  • Skin / pathology
  • Vascular Diseases* / pathology

Grants and funding

Research funded by the Italian Ministry of Health (RC 2022–2023).